Gazette.govt.nzPursuant to section 20 of the Medicines Act 1981, the Minister of Health hereby consents to the distribution in New Zealand of the new medicines which were referred to the Minister of Health under the provisions of section 24(5) of the Act and are set out in the Schedule hereto:
Schedule
| Product: | Children’s Claratyne |
| Active Ingredient: | Loratadine 1mg/mL |
| Dosage Form: | Syrup |
| New Zealand Sponsor: | Bayer New Zealand Limited |
| Manufacturer: | Delpharm Montréal Inc, Quebec, Canada |
| Product: | Suxamethonium Chloride |
| Active Ingredient: | Suxamethonium chloride dihydrate 5%w/w |
| Dosage Form: | Solution for injection |
| New Zealand Sponsor: | Max Health Limited |
| Manufacturer: | Macarthys Pharmaceuticals T/A Martindale Pharma, Romford, United Kingdom |
Dated this 11th day of August 2023.
DEREK FITZGERALD, Acting Group Manager, Medsafe, Ministry of Health (pursuant to delegation given by the Minister of Health on 11 September 2013).